I think we will see the current sp getting good support. Next company report will hopefully shed some light on the future.Congrats to the long term holders, this story is just starting to unfold.....
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%